In Vivo Protein Replacement Platform Trademark Details

This mark is dead with a status of Abandoned-Failure to Respond or Late Response. The last case file activity for this mark occured 8 years ago on Friday, October 16, 2015, according to the United State Patent & Trademark Office
Word Mark In Vivo Protein Replacement Platform
Status Dead 602 — Abandoned-Failure to Respond or Late Response

Current Owner

Sangamo Therapeutics, Inc. of Richmond, CA

View all trademarks for Sangamo Therapeutics, Inc.
Other Trademarks for Sangamo Therapeutics, Inc.
Serial Number 86241568
Status Date Friday, October 16, 2015
Filing Date Friday, October 16, 2015
Attorney Tali L. Alban

Correspondent

Tali L. Alban
KILPATRICK TOWNSEND & STOCKTON LLP
2 EMBARCADERO CTR FL 8
SAN FRANCISCO, CA 94111-3833

Case File Statements

Goods & Services Biologicals, namely, engineered cells for the in vivo production of human, animal, plant, viral, microbial and synthetic proteins for clinical and medical laboratory use in human and animal therapeutics and DNA diagnostics
Goods & Services Medical and scientific research and development, clinical testing, and consultation related thereto, all in the field of pharmaceutical preparations and drugs

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, April 16, 2014
Primary Code 005
International Class Codes
042 — Class 42 includes mainly services provided by persons, individually or collectively, in relation to the theoretical and practical aspects of complex fields of activities; such services are provided by members of professions such as chemists, physicists, engineers, computer programmers, etc.
U.S. Class Codes 100, 101
Status 6 — Active
Status Date Wednesday, April 16, 2014
Primary Code 042

You must be signed in to print.

Once signed in, look for the PDF button.